The many faces of α-synuclein: From structure and toxicity to therapeutic target

Hilal A. Lashuel, Cassia R. Overk, Abid Oueslati, Eliezer Masliah

Research output: Contribution to journalArticle

610 Citations (Scopus)


Disorders characterized by α-synuclein (α-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which α-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of α-syn and their role in regulating α-syn function in health and disease. Understanding the nature of the various α-syn structures, how they are formed and their relative contributions to α-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.

Original languageEnglish
Pages (from-to)38-48
Number of pages11
JournalNature Reviews Neuroscience
Issue number1
Publication statusPublished - 1 Jan 2013
Externally publishedYes


ASJC Scopus subject areas

  • Neuroscience(all)

Cite this